Susquehanna International Group’s BioCardia BCDA Stock Holding History

Susquehanna International Group’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,107	Closed	-$285K	–	12008
2023 Q2	$285K	Sell	7,107 -10,713	-60%	-$330K	﹤0.01%	9547
2023 Q1	$524K	Buy	17,820 +11,953	+204%	+$397K	﹤0.01%	8445
2022 Q4	$184K	Buy	5,867 +2,334	+66%	+$66.4K	﹤0.01%	10254
2022 Q3	$103K	Buy	3,533 +2,400	+212%	+$62.1K	﹤0.01%	11679
2022 Q2	$25K	Sell	1,133 -1,514	-57%	-$36.2K	﹤0.01%	12297
2022 Q1	$82K	Sell	2,647 -833	-24%	-$24.7K	﹤0.01%	12034
2021 Q4	$101K	Buy	+3,480	New	+$128K	﹤0.01%	12142
2021 Q2	–	Sell	-3,220	Closed	-$210K	–	12542
2021 Q1	$210K	Buy	+3,220	New	+$201K	﹤0.01%	11342

Other funds holding BCDA

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Susquehanna International Group's BCDA Position: Q1 2026 in Review

Susquehanna International Group increased its BioCardia (BCDA) stake by 0.05% in Q1 2026, buying an estimated $23 and bringing the position to 38,827 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #12651.

Susquehanna International Group first reported a position in BCDA in Q3 2019 and has held it in 17 quarters since. The position peaked at $266K in Q3 2022. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

Susquehanna International Group held 38,827 shares of BioCardia worth $47K as of Q1 2026.
Susquehanna International Group bought 18 BioCardia shares in Q1 2026, an estimated $23.
BioCardia made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12651 holding.
Susquehanna International Group first reported a position in BioCardia in Q3 2019 and has held it in 17 quarters since.
Susquehanna International Group's BioCardia position peaked at $266K in Q3 2022.
18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.